185 related articles for article (PubMed ID: 31939390)
41. Plateletpheresis donation through donor awareness, motivation, and recruitment drives: A unique concept and experience from a tertiary care oncology centre in India.
Ojha S; Gupta AM; Nagaraju P; Poojary M; Ravatale A
Transfus Clin Biol; 2022 Feb; 29(1):65-69. PubMed ID: 34302952
[TBL] [Abstract][Full Text] [Related]
42. Repeat plateletpheresis: the effects on the donor and the yield.
Rock G; Tittley P; Sternbach M; Buskard N; Schroeder M
Vox Sang; 1992; 63(2):102-6. PubMed ID: 1441301
[TBL] [Abstract][Full Text] [Related]
43. Comparative study of automated plateletpheresis using five different apheresis systems in a tertiary care hospital.
Chaudhary R; Das SS; Khetan D; Ojha S; Verma S
Transfus Apher Sci; 2009 Apr; 40(2):99-103. PubMed ID: 19237317
[TBL] [Abstract][Full Text] [Related]
44. The effect of plateletpheresis on the Fenwal CS-3000 on donor platelet counts.
Kalish RI; Chambers LA; Linden JV
J Clin Apher; 1987; 3(4):230-4. PubMed ID: 3680195
[TBL] [Abstract][Full Text] [Related]
45. Comparison of plateletpheresis using two cell separators and identical donors.
Bertholf MF; Mintz PD
Transfusion; 1989; 29(6):521-3. PubMed ID: 2749875
[TBL] [Abstract][Full Text] [Related]
46. Postdonation platelet counts are safe when collecting platelets with the Trima Accel using a postdonation platelet count target of > or =50,000 platelets/microL.
Alex J; Roberts B; Raife T
J Clin Apher; 2009; 24(5):215-7. PubMed ID: 19816960
[TBL] [Abstract][Full Text] [Related]
47. The impact of delayed and immediate adverse events on the intention of future donations in whole blood and plateletpheresis donors.
Gupta AM; Bajpai M
J Clin Apher; 2021 Aug; 36(4):621-627. PubMed ID: 33942928
[TBL] [Abstract][Full Text] [Related]
48. Comparison of plateletpheresis on the Fresenius AS.TEC 204 and Haemonetics MCS 3p.
Ranganathan S
J Clin Apher; 2007 Feb; 22(1):1-4. PubMed ID: 17111420
[TBL] [Abstract][Full Text] [Related]
49. Effect of long-term platelet donation on lymphocyte subsets and plasma protein concentrations.
Lewis SL; Kutvirt SG; Bonner PN; Simon TL
Transfus Sci; 1997 Jun; 18(2):205-13. PubMed ID: 10174686
[TBL] [Abstract][Full Text] [Related]
50. A prospective quality evaluation of single donor platelets (SDP) - an experience of a tertiary healthcare center in India.
Pandey P; Tiwari AK; Sharma J; Singh MB; Dixit S; Raina V
Transfus Apher Sci; 2012 Apr; 46(2):163-7. PubMed ID: 22365925
[TBL] [Abstract][Full Text] [Related]
51. The apheresis platelet donation was increased after a nationwide ban on family/replacement donation in China.
Chen J; Zhou G; Fu X; Li S; Li Y; Kang J; Chen H; Zhou L; Fu Y
BMC Public Health; 2021 Apr; 21(1):819. PubMed ID: 33926409
[TBL] [Abstract][Full Text] [Related]
52. Clinical Indications and Adverse Reactions of Platelet Apheresis.
Amanat ST; Shakoor HA; Raza M; Khan N; Rauf A
J Coll Physicians Surg Pak; 2015 Jun; 25(6):403-6. PubMed ID: 26100990
[TBL] [Abstract][Full Text] [Related]
53. Effect of plateletpheresis on hematocrit, hemoglobin and erythrocyte count: Meta-analysis 1980-2018.
Gil-Betacur A; Mantilla-Gutiérrez CY; Cardona-Arias JA
Sci Rep; 2019 Dec; 9(1):19770. PubMed ID: 31875045
[TBL] [Abstract][Full Text] [Related]
54. Reference interval of platelet counts and other platelet indices in apparently healthy blood donors in North India according to Clinical and Laboratory Standards Institute guidelines: Need to redefine the platelet count cutoffs for repeat plateletpheresis donation?
Pabbi S; Tiwari AK; Aggarwal G; Sharma G; Marik A; Luthra AS; Upadhyay AP; Singh MK
Asian J Transfus Sci; 2022; 16(2):245-250. PubMed ID: 36687539
[TBL] [Abstract][Full Text] [Related]
55. Efficacy and safety of plateletpheresis by donors with low-normal platelet counts.
Rogers RL; Johnson H; Ludwig G; Winegarden D; Randels MJ; Strauss RG
J Clin Apher; 1995; 10(4):194-7. PubMed ID: 8770712
[TBL] [Abstract][Full Text] [Related]
56. Repeat plateletpheresis--the effects on the donor and the yield.
Rock G; Tittley P; Sternbach M; Buskard N; Schroeder M
Prog Clin Biol Res; 1990; 337():27-30. PubMed ID: 2352986
[No Abstract] [Full Text] [Related]
57. Analysis of pre- and post-donation haematological values in plateletpheresis donors.
Love E; Pendry K; Hunt L
Vox Sang; 1993; 65(3):209-11. PubMed ID: 8249363
[TBL] [Abstract][Full Text] [Related]
58. Assessment of serum iron stores in regular plateletpheresis donors.
Chinigi Sab P; Kaur G; Kaur P; Tahlan A; Bedi RK; Mittal K; Sood T
Transfus Apher Sci; 2022 Feb; 61(1):103291. PubMed ID: 34649790
[TBL] [Abstract][Full Text] [Related]
59. Feasibility and safety of triple dose platelet collection by apheresis.
Moog R
J Clin Apher; 2009; 24(6):238-40. PubMed ID: 19908304
[TBL] [Abstract][Full Text] [Related]
60. Comparison of plateletpheresis on the Fenwal Amicus, Fresenius COM.TEC, and Trima Accel Cell separators.
Keklik M; Eser B; Kaynar L; Sivgin S; Keklik E; Solmaz M; Ozturk A; Buyukoglan R; Yay M; Cetin M; Unal A
J Clin Apher; 2015 Jun; 30(3):171-5. PubMed ID: 25230340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
